Health Condition 1: C541- Malignant neoplasm of endometrium
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
DrAparajita
Eligibility
Inclusion criteria
Inclusion criteria: â?? Women of any age group with proven Endometrial cancer who had undergone primary treatment
Exclusion criteria
Exclusion criteria: 1.Inability to give informed consent 2.Pregnant women 3.Other concomitant Medical conditions like acute or chronic infections, including HIV, any immunodeficiency disorders/ Inflammatory disorders/ on drugs like steroids or anti - inflammatory treatment/ haematological disorders that may affect the blood cell counts. 4.Suspected / Diagnosed with Other Gynaecological malignancy (other than Endometrial cancer) and non gyanecological malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To assess the association between Eosinophilic ratios (ELR, ENLR) with Clinical, Surgical and Pathological characteristics in patients with endometrial cancer. 2. To assess the association between Eosinophilic ratios (ELR, ENLR) with Recurrence free survival in patients with endometrial cancer. Timepoint: 1.To assess the association between Eosinophilic ratios (ELR, ENLR) with Clinical, Surgical and Pathological characteristics in patients with endometrial cancer after surgical management. 2. To assess the association between Eosinophilic ratios (ELR, ENLR) with Recurrence free survival in patients with endometrial cancer after 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the association between Eosinophilic ratios with 1.Intraoperative and Postoperative adverse events 2.Tumour histology Timepoint: JANUARY 2019 TO DECEMBER 2023 | — |
Countries
India
Contacts
Public ContactDR Jaya Chaturvedi
AIIMS RISHIKESH
Outcome results
None listed